The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
In the wake of the Food and Drug Administration’s (FDA’s) controversial decision to approve aducanumab for Alzheimer’s disease, how will, and how should, Medicare respond? We propose a coverage with ...
MCLEAN, VA, UNITED STATES, January 22, 2026 /EINPresswire.com/ — CrafterCMS, the enterprise-grade, Java-based headless CMS, announced today the release of a new ...
WASHINGTON, DC / ACCESS Newswire / March 24, 2026 / A new federal initiative allowing up to $500 annually in hemp-derived cannabinoid products for Medicare beneficiaries is raising urgent questions ...
New open-source AI skill converts HTML design templates quickly into a fully-managed website within minutes. MCLEAN, VA, UNITED STATES, January 22, 2026 /EINPresswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results